raloxifene hydrochloride has been researched along with toremifene in 27 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (25.93) | 18.2507 |
| 2000's | 15 (55.56) | 29.6817 |
| 2010's | 5 (18.52) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jordan, VC | 1 |
| Ziegler, J | 1 |
| Gradishar, WJ; Jordan, VC | 1 |
| Belanger, A; Gauthier, S; Labrie, C; Labrie, F; Merand, Y; Poirier, D; Sanchez, R; Simard, J; Singh, SM | 1 |
| Powles, TJ | 1 |
| Cohen, FJ; Mitlak, BH | 1 |
| Carthew, P; Edwards, RE; Nolan, BM | 1 |
| Cockcroft, N; Dahllund, J; Härkönen, P; Hemminki, K; Kangas, L; Koskinen, M; Laine, A; Peng, Z; Qu, Q; Väänänen, K; Zheng, H | 1 |
| Galid, A; Kubista, E; Seifert, M | 1 |
| Butterworth, M; Greaves, P; Green, A; Parrott, E; White, IN | 1 |
| Butterworth, M; Greaves, P; Green, AR; Jones, PS; Parrott, EL; White, IN | 1 |
| Gajdos, C; Jordan, VC | 1 |
| Candas, B; Couillard, S; Gutman, M; Labrie, C; Labrie, F; Roy, J | 1 |
| Alba, E; Colla, F; Farina, C; Mazzoleni, A; Ragonesi, G | 1 |
| Nagykálnai, T | 1 |
| Andrade, PM; Baracat, EC; Borra, RC; Lima, GR; Silva, ID | 1 |
| Höffken, K; Sayer, HG | 1 |
| Eckhardt, S | 1 |
| Diez-Perez, A | 1 |
| Botsis, DC; Christodoulakos, GE; Lambrinoudaki, IV | 1 |
| Cooperwood, JS; Khan, MO; Musa, MA | 1 |
| Farmakiotis, D; Katsikis, I; Kourtis, A; Panidis, D; Salmas, M; Tsourdi, E | 1 |
| Pinkerton, JV; Thomas, S | 1 |
| Alonso, M; Alonso, R; Cerrato, F; Fernández-Suárez, ME; Gómez-Coronado, D; Lasunción, MA; Mata, P; Pastor, O; Vázquez, C | 1 |
| Komm, BS; Pickar, JH | 1 |
| Blanco-Vaca, F; Dávalos, A; Escolà-Gil, JC; Fernández-Suárez, ME; Gómez-Coronado, D; Lasunción, MA; Martínez-Botas, J; Pastor, O | 1 |
| Baker, M; Blastovich, MAT; Cooper, MA; Currie, B; Elliott, AG; Han, M; Hussein, MH; Jasim, R; Li, J; Mayo, M; Morris, F; Reyes-Ortega, F; Schneider, EK; Velkov, T | 1 |
12 review(s) available for raloxifene hydrochloride and toremifene
| Article | Year |
|---|---|
Alternate antiestrogens and approaches to the prevention of breast cancer.
Topics: Animals; Breast Neoplasms; Clinical Trials as Topic; Drug Design; Estrogen Antagonists; Female; Humans; Liver Neoplasms, Experimental; Piperidines; Raloxifene Hydrochloride; Rats; Tamoxifen; Toremifene | 1995 |
Clinical potential of new antiestrogens.
Topics: Antineoplastic Agents, Hormonal; Bone Density; Drugs, Investigational; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Humans; Osteoporosis, Postmenopausal; Piperidines; Raloxifene Hydrochloride; Tamoxifen; Toremifene | 1997 |
Status of antiestrogen breast cancer prevention trials.
Topics: Antineoplastic Agents, Hormonal; Breast Neoplasms; Clinical Trials as Topic; Double-Blind Method; Endometrial Neoplasms; Estrogen Antagonists; Female; Genes, BRCA1; Humans; Italy; Neoplasms, Hormone-Dependent; Osteoporosis, Postmenopausal; Piperidines; Raloxifene Hydrochloride; Tamoxifen; Toremifene; United Kingdom; United States | 1998 |
Selective estrogen receptor modulators: a look ahead.
Topics: Estrogen Antagonists; Estrogen Replacement Therapy; Female; Humans; Piperidines; Postmenopause; Pyrrolidines; Raloxifene Hydrochloride; Receptors, Estrogen; Tamoxifen; Toremifene | 1999 |
Selective estrogen receptor modulators as a new therapeutic drug group: concept to reality in a decade.
Topics: Anticarcinogenic Agents; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cinnamates; Drug Design; Forecasting; Humans; Molecular Biology; Piperidines; Pyrrolidines; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Stilbenes; Tamoxifen; Tetrahydronaphthalenes; Thiophenes; Toremifene; Treatment Outcome | 2002 |
[Antiestrogen therapy in the treatment of breast neoplasms].
Topics: Adult; Anastrozole; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Clinical Trials as Topic; Clinical Trials, Phase III as Topic; Enzyme Inhibitors; Estrogen Antagonists; Female; Forecasting; Humans; Indoles; Letrozole; Middle Aged; Neoplasm Metastasis; Nitriles; Osteoporosis; Postmenopause; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Tamoxifen; Toremifene; Triazoles | 2002 |
[Selective estrogen receptor modulators (SERMs) in the practice].
Topics: Breast Neoplasms; Coronary Disease; Estrogen Antagonists; Estrogens; Female; Humans; Osteoporosis, Postmenopausal; Raloxifene Hydrochloride; Receptors, Estrogen; Selective Estrogen Receptor Modulators; Tamoxifen; Toremifene | 2002 |
[Perspectives for the hormonal therapy of breast cancer].
Topics: Anastrozole; Androstadienes; Antineoplastic Agents, Hormonal; Breast Neoplasms; Enzyme Inhibitors; Estradiol; Estrogen Receptor Modulators; Female; Fulvestrant; Humans; Letrozole; Nitriles; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Toremifene; Triazoles | 2003 |
The cardiovascular effects of selective estrogen receptor modulators.
Topics: Cardiovascular System; Estradiol; Female; Humans; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Tamoxifen; Toremifene | 2006 |
Medicinal chemistry and emerging strategies applied to the development of selective estrogen receptor modulators (SERMs).
Topics: Breast Neoplasms; Drug Design; Estrogen Receptor alpha; Female; Humans; Raloxifene Hydrochloride; Receptors, Estrogen; Selective Estrogen Receptor Modulators; Stilbenes; Structure-Activity Relationship; Tamoxifen; Thiophenes; Toremifene | 2007 |
Use of SERMs for treatment in postmenopausal women.
Topics: Breast Neoplasms; Clinical Trials as Topic; Dyspareunia; Estrogens, Conjugated (USP); Female; Hot Flashes; Humans; Indoles; Osteoporosis; Osteoporosis, Postmenopausal; Postmenopause; Pyrrolidines; Raloxifene Hydrochloride; Receptors, Estrogen; Selective Estrogen Receptor Modulators; Tamoxifen; Tetrahydronaphthalenes; Toremifene | 2014 |
Selective estrogen receptor modulators and the combination therapy conjugated estrogens/bazedoxifene: A review of effects on the breast.
Topics: Animals; Breast; Breast Neoplasms; Drug Therapy, Combination; Estradiol; Estrogen Antagonists; Estrogens; Estrogens, Conjugated (USP); Female; Fulvestrant; Humans; Indoles; Osteoporosis; Postmenopause; Protective Factors; Raloxifene Hydrochloride; Risk Assessment; Selective Estrogen Receptor Modulators; Tamoxifen; Toremifene | 2015 |
1 trial(s) available for raloxifene hydrochloride and toremifene
| Article | Year |
|---|---|
The effect of selective estrogen receptor modulator administration on the hypothalamic-pituitary-testicular axis in men with idiopathic oligozoospermia.
Topics: Adult; Dose-Response Relationship, Drug; Follicle Stimulating Hormone; Humans; Hypothalamo-Hypophyseal System; Luteinizing Hormone; Male; Middle Aged; Oligospermia; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Sperm Count; Sperm Motility; Tamoxifen; Testis; Testosterone; Toremifene | 2009 |
14 other study(ies) available for raloxifene hydrochloride and toremifene
| Article | Year |
|---|---|
Raloxifene, retinoids, and lavender: "me too" tamoxifen alternatives under study.
Topics: Antineoplastic Agents, Hormonal; Breast Neoplasms; Clinical Trials as Topic; Drugs, Investigational; Estrogen Antagonists; Female; Humans; Lavandula; Male; Neoplasms; Oils, Volatile; Ovarian Neoplasms; Piperidines; Plant Oils; Plants, Medicinal; Prostatic Neoplasms; Raloxifene Hydrochloride; Retinoids; Tamoxifen; Toremifene | 1996 |
Blockade of the stimulatory effect of estrogens, OH-tamoxifen, OH-toremifene, droloxifene, and raloxifene on alkaline phosphatase activity by the antiestrogen EM-800 in human endometrial adenocarcinoma Ishikawa cells.
Topics: Adenocarcinoma; Alkaline Phosphatase; Benzopyrans; Endometrial Neoplasms; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Humans; Neoplasm Proteins; Piperidines; Propionates; Raloxifene Hydrochloride; Tamoxifen; Toremifene; Tumor Cells, Cultured | 1997 |
Uterotrophic effects of tamoxifen, toremifene, and raloxifene do not predict endometrial cell proliferation in the ovariectomized CD1 mouse.
Topics: Animals; Anticarcinogenic Agents; Bromodeoxyuridine; Cell Division; Cell Nucleus; Dose-Response Relationship, Drug; Endometrium; Epithelium; Estradiol; Estrogens; Female; Hypertrophy; Mice; Organ Size; Ovariectomy; Piperidines; Raloxifene Hydrochloride; Tamoxifen; Toremifene; Uterus; Vagina | 1999 |
Selective estrogenic effects of a novel triphenylethylene compound, FC1271a, on bone, cholesterol level, and reproductive tissues in intact and ovariectomized rats.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Bone and Bones; Breast Neoplasms; Cholesterol; Estrogen Antagonists; Female; Humans; Mammary Neoplasms, Experimental; Mice; Mice, Nude; Organ Size; Osteoporosis; Ovariectomy; Raloxifene Hydrochloride; Rats; Rats, Sprague-Dawley; Reference Values; Tamoxifen; Toremifene; Transplantation, Heterologous; Tumor Cells, Cultured; Uterus | 2000 |
The oestrogen receptor and its selective modulators in gynaecological oncology.
Topics: Antineoplastic Agents, Hormonal; Cinnamates; Estrogen Antagonists; Female; Genital Neoplasms, Female; Humans; Norpregnenes; Piperidines; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Stilbenes; Tamoxifen; Thiophenes; Toremifene | 2000 |
Adenomyosis--a result of disordered stromal differentiation.
Topics: Administration, Oral; Aging; Animals; Animals, Newborn; Body Weight; Calcium-Binding Proteins; Cell Differentiation; Endometriosis; Estradiol; Female; Gene Expression Regulation; Growth Inhibitors; Insulin-Like Growth Factor II; Intercellular Signaling Peptides and Proteins; Membrane Proteins; Mice; Myometrium; Nerve Growth Factor; Oligonucleotide Array Sequence Analysis; Organ Size; Raloxifene Hydrochloride; Repressor Proteins; Selective Estrogen Receptor Modulators; Stromal Cells; Tamoxifen; Toremifene; Uterus | 2001 |
Comparisons of the effects of tamoxifen, toremifene and raloxifene on enzyme induction and gene expression in the ovariectomised rat uterus.
Topics: Animals; Antineoplastic Agents, Hormonal; Cell Culture Techniques; Creatine Kinase; Creatine Kinase, BB Form; Dose-Response Relationship, Drug; Estradiol; Female; Gene Expression Regulation; Isoenzymes; Oligonucleotide Array Sequence Analysis; Ornithine Decarboxylase; Ovariectomy; Raloxifene Hydrochloride; Rats; Rats, Wistar; Receptors, Estrogen; Reverse Transcriptase Polymerase Chain Reaction; Selective Estrogen Receptor Modulators; Tamoxifen; Toremifene; Uterus | 2001 |
Comparison of the effects of EM-652 (SCH57068), tamoxifen, toremifene, droloxifene, idoxifene, GW-5638 and raloxifene on the growth of human ZR-75-1 breast tumors in nude mice.
Topics: Animals; Breast Neoplasms; Cell Division; Cell Size; Cinnamates; Endometrium; Epithelial Cells; Estrogen Antagonists; Estrone; Female; Humans; Kinetics; Mice; Mice, Nude; Neoplasm Transplantation; Ovariectomy; Piperidines; Raloxifene Hydrochloride; Stilbenes; Tamoxifen; Toremifene; Tumor Cells, Cultured | 2002 |
Estrogen and selective estrogen receptor modulator regulation of insulin-like growth factor binding protein 5 in the rat uterus.
Topics: Animals; Base Sequence; DNA; Estrogens; Female; Insulin-Like Growth Factor Binding Protein 5; Molecular Sequence Data; Ovariectomy; Raloxifene Hydrochloride; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Selective Estrogen Receptor Modulators; Tamoxifen; Toremifene; Uterus | 2002 |
[Hormone therapy, chemotherapy and immunotherapy in breast carcinoma. The best strategy for your patient].
Topics: Adult; Age Factors; Aged; Anastrozole; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Enzyme Inhibitors; Estrogen Antagonists; Female; Humans; Immunotherapy; Letrozole; Meta-Analysis as Topic; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Nitriles; Premenopause; Prognosis; Quality of Health Care; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Risk Factors; Selective Estrogen Receptor Modulators; Tamoxifen; Time Factors; Toremifene; Trastuzumab; Triazoles | 2003 |
Selective estrogen receptor modulators (SERMS).
Topics: Biomarkers; Bone Density; Bone Remodeling; Breast Neoplasms; Female; Humans; Postmenopause; Raloxifene Hydrochloride; Risk Factors; Selective Estrogen Receptor Modulators; Tamoxifen; Toremifene | 2006 |
Clinically used selective oestrogen receptor modulators increase LDL receptor activity in primary human lymphocytes.
Topics: Cells, Cultured; Dose-Response Relationship, Drug; Down-Regulation; Hep G2 Cells; Hepatocytes; Humans; Lipoproteins, LDL; Lovastatin; Lymphocytes; Male; Raloxifene Hydrochloride; Receptors, LDL; Selective Estrogen Receptor Modulators; Structure-Activity Relationship; Tamoxifen; Toremifene | 2015 |
Clinically used selective estrogen receptor modulators affect different steps of macrophage-specific reverse cholesterol transport.
Topics: Acetyl-CoA C-Acetyltransferase; Animals; Apolipoprotein A-I; ATP Binding Cassette Transporter 1; ATP Binding Cassette Transporter, Subfamily G; Biological Transport; Cholesterol; Cholesterol Esters; Diet, Western; Esterification; Estradiol; Feces; Fulvestrant; Humans; Lipoproteins, HDL; Lipoproteins, LDL; Liver; Macrophages; Male; Mice; Mice, Inbred C57BL; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Tamoxifen; THP-1 Cells; Toremifene | 2016 |
From Breast Cancer to Antimicrobial: Combating Extremely Resistant Gram-Negative "Superbugs" Using Novel Combinations of Polymyxin B with Selective Estrogen Receptor Modulators.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Biofilms; Cell Membrane Permeability; Drug Repositioning; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Klebsiella pneumoniae; Microbial Sensitivity Tests; Polymyxin B; Pseudomonas aeruginosa; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Tamoxifen; Toremifene | 2017 |